NCT06162858 Reaching Motion During Functional Activities
| NCT ID | NCT06162858 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Shoulder Arthropathy Associated With Other Conditions |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-10-15 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-10-15 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Taking and moving objects is essential. When this becomes difficult, it affects daily functioning. This study aims to determine movement patterns, at the level of the shoulder, during different functional movements in elderly people aged 60 years and older. Movement patterns of people without shoulder problems and patients with a reverse shoulder prosthesis will be compared. These insights can contribute to improving functional rehabilitation in patients with a reverse shoulder prosthesis (RSA).
Eligibility Criteria
Inclusion Criteria: * 60 years and older * no shoulder pain + no diagnosis of shoulder problem * primary reverse shoulder arthroplasty Exclusion Criteria: * younger than 60 years * shoulder pain at moment of testing * known shoulder problem ( incl. diagnosis)
Contact & Investigator
Alexander Van Tongel, PhD
PRINCIPAL INVESTIGATOR
University Hospital Ghent, University Ghent
Frequently Asked Questions
Who can join the NCT06162858 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Shoulder Arthropathy Associated With Other Conditions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06162858 currently recruiting?
Yes, NCT06162858 is actively recruiting participants. Contact the research team at dominiek.vandenbosch@ugent.be for enrollment information.
Where is the NCT06162858 trial being conducted?
This trial is being conducted at Ghent, Belgium, Ghent, Belgium.
Who is sponsoring the NCT06162858 clinical trial?
NCT06162858 is sponsored by University Hospital, Ghent. The principal investigator is Alexander Van Tongel, PhD at University Hospital Ghent, University Ghent. The trial plans to enroll 100 participants.